Skip to main content
China Medical System Holdings Limited logo

China Medical System Holdings Limited — Investor Relations & Filings

Ticker · 867 ISIN · KYG211081248 LEI · 529900Z57DVJXUBLHX66 HKEX Manufacturing
Open in API
Filings indexed 766 across all filing types
Latest filing 2026-06-08 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 867

About China Medical System Holdings Limited

http://www.cms.net.cn

China Medical System Holdings Limited (CMS) is an innovation-driven specialty pharmaceutical group engaged in the development, manufacturing, marketing, promotion, and sales of pharmaceutical products. The company focuses on delivering competitive products and services that enhance clinical value in disease diagnosis and treatment. CMS maintains a strong commercial presence in the specialty drug market. Its strategy combines established commercialization capabilities with an active R&D pipeline. A notable component of its pipeline is the self-developed innovative drug CMS-D017, a selective Complement Factor B (CFB) small molecule inhibitor. This drug is being developed for treating complement dysregulation-related inflammatory and autoimmune diseases, including Paroxysmal Nocturnal Hemoglobinuria (PNH).

Recent filings

Filing Released Lang Actions
Share Buy Back - Daily Share Buy-Back Notice::Daily Share Buy-Back Notice
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return filed under Hong Kong Exchange rules, detailing share repurchases, treasury share movements, and on‐market sales of own shares. It provides the number of shares repurchased, prices, and closing balances—characteristics of a Transaction in Own Shares filing rather than a broader financial report or simple announcement. Hence, it falls under the “Transaction in Own Shares” category (POS).
2026-06-08 English
Share Buy Back - Daily Share Buy-Back Notice::Daily Share Buy-Back Notice
Transaction in Own Shares Classification · 90% confidence The document is a Hong Kong Exchange “Next Day Disclosure Return” (Form FF305) detailing changes in issued shares and treasury shares, specifically share repurchases (on-market buybacks) and treasury share movements. It includes transaction dates, quantities repurchased, prices, and confirmations under Main Board/GEM rules. This clearly falls under reporting of a company’s own share transactions. According to the filing definitions, it matches Transaction in Own Shares (Code: POS).
2026-06-04 English
Share Buy Back - Daily Share Buy-Back Notice::Daily Share Buy-Back Notice
Transaction in Own Shares Classification · 95% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) detailing changes in issued shares and treasury shares, including share repurchases and on‐market sales of treasury shares. It is a disclosure of transactions in the company’s own shares (buybacks and treasury movements), not a broader financial report, earnings release, or management announcement. This matches the Filing category “Transaction in Own Shares” (Code: POS).
2026-06-03 English
Share Buy Back - Daily Share Buy-Back Notice::Daily Share Buy-Back Notice
Transaction in Own Shares Classification · 92% confidence The document is a Next Day Disclosure Return (Form FF305) filed under Hong Kong Stock Exchange rules, detailing the company’s changes in issued shares and repurchase of shares (treasury shares), including on-market repurchase dates, prices, and balances. This is a transaction report of the company buying back its own shares, matching the definition for Transaction in Own Shares (POS).
2026-06-02 English
Share Buy Back - Daily Share Buy-Back Notice::Daily Share Buy-Back Notice
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return (FF305) under Hong Kong Stock Exchange listing rules detailing changes in issued shares and treasury shares, including on-market repurchase of shares and treasury sale. It is a regulatory announcement of the company’s own share transactions (repurchases and treasury sales). This matches the “Transaction in Own Shares” filing category.
2026-06-01 English
General Announcement::Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Regulatory Filings Classification · 80% confidence The document is a "Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules" providing compliance data on share capital movements, issued and treasury shares, repurchases and public float sufficiency for the month ended 31 May 2026. It is a regular regulatory listing rule filing to the Hong Kong Stock Exchange rather than a financial report, management discussion, transaction-specific announcement, or investor presentation. Therefore it best fits under the general Regulatory Filings category.
2026-06-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.